> Nephros, Inc. (NEPH) is currently waiting on two FDA approvals for two
> hemodiafiltration devices (which could happen any day this week).
> These two approvals should happen on the same day. Nephros has already
> received approval from the FDA for one device earlier last month. As
> of right now, the FDA has approved EVERY device application that has
> come across their desks this year. This is as sure of a thing as  you
> can get.

> As of right now, Nephros has had 11 straight trading days of gains
> (going from 1.265 to a Tuesday closing price of $2.28 during that
> time). That's a total of 80.24% in just 11 days. Since July 1st, it
> has seen 123.53% in gains. Monday saw some gains of 14 cents after the
> positive earnings report that came out Friday after the closing bell.
> Tuesday saw some incredible gains of 43 cents. Approval can happen
> anytime this week. Get in now before it is too late.